PLATO Study of Ticagrelor Versus Clopidogrel in Patients With High-Risk Acute Coronary Syndromes
- 255 Downloads
Dr. Neal S. Kleiman has received clinical research funding from Bristol-Myers Squibb, Sanofi-Aventis, and Eli Lilly and Co.
- 1.Patti G, Colonna G, Pasceri V, et al.: Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Results from the ARMYDA-2 (Antiplatelet therapy for Reduction of Myocardial Damage during Angioplasty) Study. Circulation 2005, 111:2099–2106.CrossRefPubMedGoogle Scholar
- 2.Cardiobrief: ESC: CURRENT-OASIS 7 misses primary endpoint, but high dose clopidogrel aids PCI for ACS. Available at http://cardiobrief.org/2009/08/30/esc-high-dose-clopidogrel-aids-pci-for-acs-current-oasis-7. Accessed March 25, 2010.